Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Stoke Therapeutics Inc (STOK)

195 + Investors. Track Smart Money conviction in STOK. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +10
Streak
4Q ▲
Buyers last Q
59%

Smart Money Signals — STOK

Based on 195 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added STOK than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
195 hedge funds hold STOK right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +57% more funds vs a year ago

fund count last 6Q
+71 new funds entered over the past year (+57% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 59% buying

121 buying84 selling
Last quarter: 121 funds bought or added vs 84 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~40 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 26 → 38 → 45 → 40. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 37% long-term, 35% new

■ 37% conviction (2yr+) ■ 28% medium ■ 35% new
Of the 195 current holders: 73 (37%) held >2 years, 54 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📈

Growing discovery — still being found

25 → 26 → 38 → 45 → 40 new funds/Q
New funds entering each quarter: 26 → 38 → 45 → 40. A growing number of institutions are discovering STOK each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 48% veterans vs 36% newcomers

■ 48% veterans ■ 15% 1-2yr ■ 36% new
Entry-cohort mix of 203 holders: 98 (48%) are 2+ year veterans, 31 entered 1–2 years ago, and 74 (36%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
51 of 195 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in STOK. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.7
out of 10
Moderate Exit Risk
Exit risk score 4.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — STOK

In 2026 Q1, 121 hedge funds were net buyers of STOK (40 opened a new position, 81 added to an existing one), while 84 reduced or exited (54 trimmed, 30 sold completely) — a 59% buyer ratio, indicating a slight buying edge. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 40% of total institutional value in STOK is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +10 funds (more new holders than closures). Total institutional holders: 195.

Hedge Fund Ownership: STOK

How many hedge funds hold STOK — quarterly history vs. share price
Quarterly hedge fund ownership of STOK vs. share price

Market Analysis: STOK

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: STOK

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Stoke Therapeutics Inc (STOK) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much STOK has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 47d ago
STOK
-4.4%
XLV
+5.5%

STOK outperformed XLV by -9.9% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 2d ago
STOK
+0.0%
XLV
+0.0%

Since the filing became public, STOK outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

19 top-rated funds 1 high-conviction
Consensus
5.6
/ 10
breadth
×
Elite
2.3
/ 10
conviction
Hedge Fund Positioning: STOK
2026 Q2 Stats Unlock in 3 days 195 + Investors

Track Smart Money conviction in STOK. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 195 184 5.98%
13F Shares 70M 68M 2.86%
Total Value $2.19B $2.14B 2.61%
New Positions 40 45 -5
Increased Positions 79 56 +23
Closed Positions 29 11 +18
Reduced Positions 53 59 -6
Total Calls 4 6 -33.33%
Total Puts 4 3 33.33%
PUT/CALL Ratio 1.0 0.5 Neutral

Statistics: STOK

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

195 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in STOK. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 STOK holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lynx1 Capital Management LP 26.03% 4,038,404 $132.1M
2 Redmile Group, LLC 8.67% 3,945,920 $129.1M
3 Birchview Capital, LP 2.73% 178,110 $5.8M
4 Bvf Inc/Il 2.13% 2,547,557 $83.4M
5 Opaleye Management Inc. 2.07% 700,000 $22.9M
6 Troluce Capital Advisors LLC 1.67% 496,416 $16.2M
7 Rtw Investments, LP 1.57% 5,623,525 $184.0M
8 MPM BioImpact LLC 1.44% 723,314 $23.7M
9 Siren, L.L.C. 1.32% 1,995,347 $65.3M
10 Parkman Healthcare Partners LLC 1.19% 355,443 $11.6M
11 EcoR1 Capital, LLC 1.17% 735,000 $24.0M
12 DAFNA Capital Management LLC 0.82% 130,875 $4.3M
13 Deerfield Management Company, L.P. 0.62% 1,823,500 $59.7M
14 Baker BROS. Advisors LP 0.55% 3,336,697 $109.2M
15 Granahan Investment Management, LLC 0.54% 461,608 $15.1M
16 HighVista Strategies LLC 0.46% 61,316 $2.0M
17 Tang Capital Management LLC 0.45% 300,000 $9.8M
18 Platinum Investment Management Ltd 0.33% 40,815 $1.3M
19 Hussman Strategic Advisors, INC. 0.32% 42,000 $1.4M
20 EntryPoint Capital, LLC 0.24% 25,926 $350K
21 Generali Investments, Management Co LLC 0.24% 33,149 $1.1M
22 PSP Research LLC 0.21% 12,000 $393K
23 Rhenman & Partners Asset Management AB 0.20% 64,500 $2.1M
24 Yorktown Management & Research Co Inc 0.18% 9,150 $299K
25 Toronto Dominion Bank 0.12% 3,173,258 $103.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Stoke Therapeutics Inc (STOK)

What does the Smart Money Trend signal show for STOK?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added STOK than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for STOK?

Slight buying edge — 59% buying: Last quarter: 121 funds bought or added vs 84 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for STOK holders?

Elite ownership — 40% AUM from top-100 funds: 51 of 195 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in STOK. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held STOK?

Mixed — 37% long-term, 35% new: Of the 195 current holders: 73 (37%) held >2 years, 54 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Stoke Therapeutics Inc (STOK) following the 2026 Q2 hedge fund 13F filings?

As of today, STOK has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), STOK has gained -4.4% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →